Philips Secures FDA Clearance for Rembra CT, RT Systems Enabling 270 Exams Daily
Philips has received FDA 510(k) clearance for its Rembra CT, Rembra RT, and Areta RT systems, enabling up to 270 exams per day with an 85 cm bore and 4DCT imaging for precise tumor targeting. The platform integrates diagnostic radiology and radiation therapy workflows to streamline cancer care planning.
1. FDA Clearance Details
Philips has received 510(k) clearance from the U.S. FDA for its Rembra platform, which includes Rembra CT, Rembra RT and Areta RT, enabling use in both diagnostic imaging and radiation therapy planning across frontline care and cancer treatment planning.
2. Platform Performance and Capabilities
The Rembra CT scanner features an 85 cm bore and supports up to 270 exams per day based on a sixteen-hour operation, while Rembra RT and Areta RT deliver next-generation 4DCT imaging and an extended 85 cm field of view for high-fidelity treatment planning.
3. Clinical Impact and Workflow Integration
By unifying diagnostic radiology and radiation therapy planning within a single ecosystem, the Rembra platform streamlines simulation workflows, reduces variability, and supports connected care from rapid assessment in emergency settings to precise, personalized cancer treatment planning.